- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Observational Cohort Study
- Objective: To assess the safety, virological, and clinical outcomes of convalescent plasma transfusion in immunocompromised patients hospitalised for COVID-19
- Number of participants enrolled: 81
- Study enrolling from to
- Study includes follow-up for 1
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Immunocompromised host
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Non pharmacological intervention
- Convalescent plasma
External Links
Other information
Funders/Sponsors:
- Test Funder 1
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to